Essential Strategies for Successful Out-Licensing and Partnering in Pharma and Biotech Industry Dealmaking in the pharmaceutical and biotech industries plays a pivotal role in fostering growth and innovation. Partnering and…
Pharmaceutical R&D Trends 2025: Key Insights and Strategic Shifts The pharmaceutical industry is at a critical inflection point in 2025, with research and development (R&D) continuing to grow despite global…
How to Gather Competitive Intelligence in the Pharma Sector Understanding competition is fundamental to success in any industry. This is especially critical in the biopharmaceutical sector, which is highly capital-intensive…
How to Navigate the Discount Rate Conundrum in Biotech and Pharma Valuation In the pharmaceutical and biotechnology industry (referred to collectively as biopharma), almost all valuation and investment decisions decisions…
Pharma Competitive Intelligence: Warning Signs of Subpar Intelligence In the fiercely competitive pharmaceutical landscape, comprehensive and strategic competitive intelligence (CI) is crucial for success. Pharmaceutical companies rely on gaining insights…
Key Success Factor in Pharma Search and Evaluation and Due Diligence Licensing and partnering are critical growth strategies in the biopharma industry. The effectiveness of licensing and partnership relies heavily on…
Enhancing Biopharma Licensing and Partnering Through Comparative Evaluation The biopharmaceutical industry landscape is constantly evolving, and in-licensing and partnering deals are vital corporate strategies for driving innovation, devising new products,…
Strategies to Optimize Pharma Competitive Intelligence for Maximum ROI Competitive intelligence (CI) is a widely used decision-making tool in the biopharma industry. In order to seek competitive advantage, pharma and…
Effectively Integrating Competitor Analysis into New Product Planning to Maximize Biopharma Asset Value In the biopharmaceutical industry, the predominant focus of New Product Planning (NPP) initiatives often revolves around individual…
Finessing Pharma and Biotech Product Strategies in the Post-Inflation Reduction Act Era The recent passage of the Inflation Reduction Act (IRA) introduces sweeping changes for the biopharmaceutical industry through new…